| Literature DB >> 26184257 |
Luz T Padró-Martínez1, Emmanuel Owusu2, Ellen Reisner3, Wig Zamore4, Matthew C Simon5, Mkaya Mwamburi6, Carrie A Brown7, Mei Chung8, Doug Brugge9, John L Durant10.
Abstract
Exposure to traffic-generated ultrafine particles (UFP; particles <100 nm) is likely a risk factor for cardiovascular disease. We conducted a trial of high-efficiency particulate arrestance (HEPA) filtration in public housing near a highway. Twenty residents in 19 apartments living <200 m from the highway participated in a randomized, double-blind crossover trial. A HEPA filter unit and a particle counter (measuring particle number concentration (PNC), a proxy for UFP) were installed in living rooms. Participants were exposed to filtered air for 21 days and unfiltered air for 21 days. Blood samples were collected and blood pressure measured at days 0, 21 and 42 after a 12-hour fasting period. Plasma was analyzed for high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor alpha-receptor II (TNF-RII) and fibrinogen. PNC reductions ranging from 21% to 68% were recorded in 15 of the apartments. We observed no significant differences in blood pressure or three of the four biomarkers (hsCRP, fibrinogen, and TNF-RII) measured in participants after 21-day exposure to HEPA-filtered air compared to measurements after 21-day exposure to sham-filtered air. In contrast, IL-6 concentrations were significantly higher following HEPA filtration (0.668 pg/mL; CI = 0.465-0.959) compared to sham filtration. Likewise, PNC adjusted for time activity were associated with increasing IL-6 in 14- and 21-day moving averages, and PNC was associated with decreasing blood pressure in Lags 0, 1 and 2, and in a 3-day moving average. These negative associations were unexpected and could be due to a combination of factors including exposure misclassification, unsuccessful randomization (i.e., IL-6 and use of anti-inflammatory medicines), or uncontrolled confounding. Studies with greater reduction in UFP levels and larger sample sizes are needed. There also needs to be more complete assessment of resident time activity and of outdoor vs. indoor source contributions to UFP exposure. HEPA filtration remains a promising, but not fully realized intervention.Entities:
Keywords: HEPA; biomarkers; highway; in-home filtration; inflammation; ultrafine particles
Mesh:
Substances:
Year: 2015 PMID: 26184257 PMCID: PMC4515693 DOI: 10.3390/ijerph120707814
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Map of study area and locations of participant apartments. Orthophoto was downloaded from MassGIS [44].
Demographic and health data of the total study population and stratified by intervention order.
| Category | Total | HEPA First a | Sham First b |
|---|---|---|---|
| ( | ( | ( | |
|
| |||
| Age, Mean (SD), years | 53.6 (9.2) | 55.6 (11.4) | 51.5 (6.3) |
| BMI, Median (Range) | 31.5 (20–72) | 30.5 (20–72) | 32 (25–51) |
| Female | 16 (80%) | 7 (70%) | 9 (90%) |
| Born in USA | 4 (20%) | 2 (20%) | 2 (20%) |
| White | 6 (30%) | 2 (20%) | 4 (40%) |
| Hispanic | 7 (35%) | 3 (30%) | 4 (40%) |
| Household income: <$24,999/year | 14 (70%) | 8 (80%) | 6 (60%) |
| Household income: $25,000–$74,999/year | 3 (15%) | 1 (10%) | 2 (20%) |
| Household income: Don’t Know/Refused | 3 (15%) | 1 (10%) | 2 (20%) |
| High School Diploma or Higher Degree | 8 (40%) | 4 (40%) | 4 (40%) |
| Employed | 9 (45%) | 3 (30%) | 6 (60%) |
| Distance to I-93: ≤100 m | 10 (50%) | 6 (60%) | 4 (40%) |
| Distance to I-93: 101–200 m | 10 (50%) | 4 (40%) | 6 (60%) |
|
| |||
| Total Cholesterol, mean (SD), mg/dL | 290 (122) | 264 (124) | 317 (120) |
| Triglycerides, mean (SD), mg/dL | 211 (141) | 169 (111) | 254 (160) |
| Systolic Blood Pressure, mean (SD), mmHg | 123 (15) | 126 (15) | 120 (14) |
| Diastolic Blood Pressure, mean (SD), mmHg | 77 (10) | 80 (10) | 75 (9) |
| Pulse pressure, mean (SD), mmHg | 45 (10) | 46 (11) | 45 (9) |
| Previous Heart Attack | 1 (5%) | 1 (10%) | 0 (0%) |
| Diabetes | 2 (10%) | 0 (0%) c | 2 (20%) |
| High Blood Pressure | 11 (55%) | 8 (80%) | 3 (30%) |
| Anti-hypertension medicine | 10 (50%) | 7 (70%) | 3 (30%) |
| Anti-inflammatory medicine | 7 (35%) | 6 (60%) | 1 (10%) |
| Anti-lipids medicine | 3 (15%) | 2 (20%) | 1 (10%) |
| Anti-diabetes medicine | 3 (15%) | 1 (10%) | 2 (20%) |
| Former cigarette smoker | 4 (20%) | 3 (30%) | 1 (10%) |
Notes: HEPA filtration 0–21 days followed by sham filtration 21–42 days; Sham filtration 0–21 days followed by HEPA filtration 21–42 days; One participant did not answer this question on the survey; childcare provider, grocery bagger, cook (2), courier, hotel housekeeper, assistant teacher, eldercare provider, merchandise coordinator; The first five parameters in this category were measured for each participant; the remainder were self-reported; Average of the right and left arm measurements (from three clinical visits); Difference between average systolic and diastolic blood pressure.
Figure 2Box plots of all PNC measurements from each participant’s apartment stratified by filter order: (a) sham for first 21 days followed by HEPA for last 21 days; (b) HEPA for first 21 days followed by sham for last 21 days. The whiskers represent the 5th and 95th percentiles; open circles represent the median PNC values. Note that the apartments are not numbered in chronological order (see Table 2).
Summary of PNC measurements for each apartment.
| Apt. # a | Start Date | Median PNC b | PNC Reduction | Indoor Spikes (%) e | # of Res. f | Notes g | |||
|---|---|---|---|---|---|---|---|---|---|
| Sham | HEPA | % c | Abs. d | ||||||
|
| |||||||||
| 1 | 11 February 2011 | 8900 | 5000 | <0.001 | 44% | 3900 | 0.00 | 2 | K, GS, D100 |
| 2 | 25 May 2011 | 33,000 | 26,000 | <0.001 | 21% | 6900 | 16 | 5+ | K, GS, AC, D100 |
| 3 | 13 July 2011 | 5300 | 2100 | <0.001 | 60% | 3200 | 7.5 | 3 | O, K, F, D200 |
| 4 | 31 August 2011 | 19,000 | 8700 | <0.001 | 54% | 10,000 | 9.0 | 2 | CS, D100 |
| 5 | 2 November 2011 | 9000 | 3900 | <0.001 | 57% | 5200 | 3.2 | 2 | D100 |
| 6 | 19 January 2012 | 10,000 | 5700 | <0.001 | 43% | 4600 | 5.4 | 3 | O, DR, K, D200 |
| 7 | 10 March 2012 | 6900 | 3100 | <0.001 | 55% | 3800 | 2.6 | 3 | K, D200 |
| 8 | 4 May 2012 | 8400 | 6700 | <0.001 | 20% | 1700 | 1.1 | 2 | O, DR, K, D200 |
| 9 | 29 May 2012 | 9900 | 3900 | <0.001 | 61% | 6000 | 4.7 | 4 | O, DR, K, AC |
| 10 | 21 September 2012 | 6200 | 3100 | <0.001 | 50% | 3200 | 0.12 | 2 | K, D200 |
|
| |||||||||
| 11 | 11 February 2011 | 10,000 | 5800 | <0.001 | 42% | 4300 | 5.5 | 3 | DR, D100 |
| 12 | 24 May 2011 | 9100 | 2900 | <0.001 | 68% | 6100 | 5.3 | 5 | K, D100 |
| 13 | 12 July 2011 | 5500 | 2200 | <0.001 | 60% | 3300 | 4.9 | 5 | K, F, D100 |
| 14 | 23 September 2011 | 12,000 | 7300 | <0.001 | 39% | 5000 | 3.3 | 3 | O, DR, K, AC, D200 |
| 15 | 2 November 2011 | 5900 | 6000 | 0.87 | No diff. | No diff. | 1.8 | 4 | O, DR, K, D100 |
| 16 | 19 January 2012 | 6400 | 6400 | 0.53 | No diff. | No diff. | 0.30 | 4 | K, GS, D100 |
| 17 | 13 March 2012 | 21,000 | 33,000 | <0.001 | - | - | 11 | 3 | K, GS, D100 |
| 18 | 18 July 2012 | 13,000 | 16,000 | <0.001 | - | - | 9.3 | 3 | O, K, D200 |
| 19 | 14 September 2012 | 4000 | 5300 | <0.001 | - | - | 1.8 | 2 | O, DR, K, D200 |
Notes: The apartment numbering sequence is arbitrary and not in chronological order; Median particle number concentration (particles/cm3) based on all measurements made at each apartment; Percent reduction in median PNC due to HEPA filtration compared to sham; Absolute reduction in median PNC due to HEPA filtration compared to sham; Percentage of total PNC measurements >105 particles/cm3. Indoor sources likely include cooking and cleaning activities as well as resuspension of settled particles; Number of residents living in the apartment during the study; O = Another apartment building obstructed the direct pathway between the apartment and I-93; DR = dining room window open during the study; K = kitchen window open during the study; GS = gas stove; AC = air conditioner used at night only; F = floor fan (in LR in apartment 3, in DR in apartment 13); D100 = apartment is ≤100 m from I-93; D200 = apartment is between 101 and 200 m from I-93; AC was only used during days 21–42. Abbreviations: No diff. = no difference in median PNC between HEPA and sham filtration.
Figure A1Time-series plots of 1-minute-averaged PNC for three apartments shows the impact of spikes presumably related to indoor activities such as cooking, cleaning, and candle and incense burning.
Results of filtration experiments in an unoccupied furnished bedroom.
| Source | PNC Reduction (%) a,b | |
|---|---|---|
| Sham filter | HEPA filter | |
| None | 14 ± 5.8 | 85 ± 3.6 |
| Low concentration, continuous | 12 ± 5.6 | 74 ± 11 |
| High concentration | ||
| Discrete (candle, just after being extinguished) | 83 ± 0.84 | 95 ± 0.41 |
| Continuous (a burning candle) | −32 ± 4.3 | −13 ± 7.5 |
Notes: PNC reduction was measured as the difference in PNC averaged over the 30 min prior to HEPA being turned on and PNC averaged over the 10–40 min after HEPA was turned on. For the discrete source, PNC reduction was measured as the difference in PNC averaged over the 30 min prior to HEPA being turned on and the average PNC over the 10–40 min after the source was turned off; Mean ± standard deviation (SD), n = 3 (except for sham filter with no source where n = 2); None = no candle; windows closed; Window was opened 70 cm (area of opening was 2800 cm2) allowing ambient air to enter the room and serve as a continuous source; Measurements were performed with HEPA running continuously before and after the candle was extinguished. For the case where the HEPA was turned off (no HEPA or sham filtration), PNC in the room decreased to 77% ± 0.62% after 30 min. Between 400–600 min after the candle was extinguished, PNC reduction due to HEPA and sham filtration were 99.99% ± 0.0072% and 99.42% ± 0.13%, respectively; Measurements were performed with candle burning continuously before and after the HEPA was turned on.
Figure A2Results of HEPA and sham filtration experiments in an unoccupied bedroom for three PNC-source conditions: (a) no source, (b) low concentration, continuous source (ambient air through an open window), and (c) high concentration, discrete source (a lit candle that was extinguished at t = 30 min (note that HEPA was on at t = 0 min)). Solid lines represent the mean of three replicate experiments; dashed lines represent the standard error (SE). * The increase in PNC was due to an outdoor source that coincided with one of the three repetitions of the experiment.
Differences in change in blood biomarker and blood pressure measurements due to filtration.
| Health Measure | Absolute Difference (95% CI): Sham | % Difference (95% CI): Sham |
|---|---|---|
| hsCRP (mg/L) | 1.05 (0.526–2.11) | 5.02 (−45.1–55.1)% |
| Fibrinogen (mg/dL) | −21.0 (−92.6‒50.6) | 64.2 (−154–283)% |
| TNF-RII (pg/mL) | 0.984 (0.862–1.12) | −1.72 (−14.1–10.7)% |
| IL-6 (pg/mL) | 0.668 (0.465–0.959) | −49.6 (−93.3–−5.90)% |
| Systolic BP (mm Hg) | 8.19 (−0.991‒17.4) | 266 (−321–564)% |
| Diastolic BP (mm Hg) | 4.28 (−3.89‒12.4) | 367 (−333–1070)% |
| Pulse Pressure (mm Hg) | 3.92 (−4.46‒12.3) | 204 (−233–641)% |
Notes: mean of measurements following 21-day of sham filtration (adjusted for baseline) minus mean of measurements following 21-day of HEPA filtration (adjusted for baseline). CI = confidence interval. hsCPR, TNF-RII, and IL-6 concentrations were first log transformed (natural log) prior to paired t-test; the inverse logs were used in the absolute and % difference calculations; % difference = ((mean of Sham change—mean of HEPA change)/mean of Sham change) × 100. A % difference >100% indicates a greater reduction in effect during HEPA filtration relative to sham; a % difference >0% and <100% indicates a lesser reduction in effect during HEPA relative to sham; a % difference <0% indicates an increase in effect during HEPA filtration relative to sham. * Significant differences (i.e., p ≤ 0.05) between sham and HEPA were observed only for IL-6.
Blood biomarker concentrations and blood pressure measurements stratified by filter order.
| Health Measure | Sham First (0–21 Day), HEPA Second (21–42 Day) ( | HEPA First (0–21 Day), Sham Second (21–42 Day) ( | ||||
|---|---|---|---|---|---|---|
| Day of collection | 0 | 21 | 42 | 0 | 21 | 42 |
| hsCRP (median (Q1–Q3)) (mg/L) | 2.46 (1.75–4.28) | 1.45 (1.28–2.29) | 1.77 (1.27–2.66) | 3.16 (2.16–8.33) | 2.97 (0.76–8.17) | 5.87 (1.01–11.1) |
| Fibrinogen (mean ± SD) (mg/dL) | 460 ± 104 | 415 ± 64 | 410 ± 78 | 477 ± 132 | 459 ± 133 | 439 ± 138 |
| TNF-RII (median (Q1–Q3)) (ng/mL) | 2.28 (1.64–2.86) | 2.23 (1.92–2.92) | 2.28 (1.77–2.42) | 2.49 (1.98–2.92) | 2.39 (2.10–2.89) | 2.14 (1.98–2.70) |
| IL-6 (median (Q1–Q3)) (pg/mL) | 2.10 (1.13–2.89) | 1.27 (0.92–1.70) | 1.43 (1.10–2.41) | 1.58 (1.05–3.32) | 1.86 (1.40–3.97) | 1.70 (1.28–3.22) |
| Systolic BP (mean ± SD) (mm Hg) | 122 ± 17 | 120 ± 14 | 118 ± 12 | 131 ± 12 | 121 ± 13 | 128 ± 18 |
| Diastolic BP (mean ± SD) (mm Hg) | 77 ± 10 | 74 ± 8 | 73 ± 9 | 82 ± 9 | 78 ± 9 | 81 ± 13 |
| Pulse pressure (mean ± SD) (mm Hg) | 45 ± 10 | 46 ± 11 | 45 ± 8 | 49 ± 13 | 43 ± 12 | 47 ± 9 |
Notes: number of participants. Abbreviations: Q1 and Q3 are first and third quartile, SD is one standard deviation, BP is blood pressure.
Percent change from baseline and 95% confidence intervals (CI) for adjusted mean blood biomarker concentrations based on generalized estimation equation model. Means adjusted for baseline blood biomarker concentrations. All variables were analyzed in log scale and transformed prior to reporting.
| Blood Biomarker | HEPA 1st (0–21 Day) | Sham 2nd (21–42 Day) | Sham 1st (0–21 Day) | HEPA 2nd (21–42 Day) | ||||
|---|---|---|---|---|---|---|---|---|
| Adj. Mean Change | CI | Adj. Mean Change | CI | Adj. Mean Change | CI | Adj. Mean Change | CI | |
| hsCRP (mg/L) | −5% | −48%–76% | 34% | −26%–144% | −15% | −39%–19% | 6% | −10%–25% |
| Fibrinogen (mg/dL) | −2% | −12%–9% | −5% | −17%–8% | −8% | −17%–1% | −4% | −14%–7% |
| TNF-RII (pg/mL) | 2% | −5%–9% | −6% | −15%–5% | 2% | −6%–10% | −2% | −11%–7% |
| IL-6 | 24% | 9%–40% | −12% | −32%–13% | −24% | −49%–13% | 8% | −9%–28% |
Notes: Means were adjusted for baseline blood biomarker concentrations. For HEPA 1st and sham 1st, baseline = blood sample collected on day 0; for HEPA 2nd and sham 2nd, baseline = blood sample collected on day 21. All variables were analyzed on the log scale. Values in the table have been converted to normal scale by taking the exponent of the least squared mean for that variable. * Significant differences (i.e., p ≤ 0.05) between HEPA 1st and sham 1st were observed only for IL-6.
Mean change and 95% confidence intervals (CI) in blood biomarker concentrations per 104 particles/cm3 increase in PNC moving average (MA) (14- or 21-day MA) adjusted for baseline blood biomarker concentrations.
| Biomarker | MA14 | MA21 | ||
|---|---|---|---|---|
| exp (β) | CI | exp (β) | CI | |
| hsCRP (mg/L) | −24% | −59–43% | −24% | −31–−16% |
| Fibrinogen (mg/dL) | −1% | −6–5% | −1% | −6–5% |
| TNF-RII (pg/mL) | 2% | 0–4% | 2% | 0–4% |
| IL-6 (pg/mL) | −19% | −35–−1% | −18% | −18–−1% |
Notes: * p < 0.05; ** p < 0.10.
Mean change and 95% confidence interval (CI) in blood (BP) and pulse pressure (PP) per 104 particles/cm3 in PNC (Lag0, Lag1, Lag2, and 3-day moving average (MA3)) after adjustment for baseline blood and pulse pressure, respectively.
| BP/PP | Lag0 | Lag1 | Lag2 | MA3 | ||||
|---|---|---|---|---|---|---|---|---|
| β | CI | β | CI | β | CI | β | CI | |
| Systolic BP | 0.32 | −4.93–5.57 | −5.92 | −12.3–0.51 | −4.96 | −15.2–5.29 | −2.36 | −11.4–6.66 |
| Diastolic BP | 2.73 | −2.66–8.12 | −4.45 | −8.45–−0.45 | 1.17 | −7.16–9.50 | 2.38 | −5.17–9.93 |
| Average PP | −2.88 | −4.88–−0.88 | −2.45 | −7.66–2.76 | −5.80 | −9.52–−2.08 | −4.36 | −7.42–−1.30 |
Notes: * p ≤ 0.05; ** p ≤ 0.10. BP and PP are in units of mm Hg.